TY  - JOUR
AU  - Ayala, Rosa
AU  - Carreño-Tarragona, Gonzalo
AU  - Barragán, Eva
AU  - Boluda, Blanca
AU  - Larráyoz, María J
AU  - Chillón, María Carmen
AU  - Carrillo-Cruz, Estrella
AU  - Bilbao, Cristina
AU  - Sánchez-García, Joaquín
AU  - Bernal, Teresa
AU  - Martinez-Cuadron, David
AU  - Gil, Cristina
AU  - Serrano, Josefina
AU  - Rodriguez-Medina, Carlos
AU  - Bergua, Juan
AU  - Pérez-Simón, José A
AU  - Calbacho, María
AU  - Alonso-Domínguez, Juan M
AU  - Labrador, Jorge
AU  - Tormo, Mar
AU  - Amigo, Maria Luz
AU  - Herrera-Puente, Pilar
AU  - Rapado, Inmaculada
AU  - Sargas, Claudia
AU  - Vazquez, Iria
AU  - Calasanz, María J
AU  - Gomez-Casares, Teresa
AU  - García-Sanz, Ramón
AU  - Sanz, Miguel A
AU  - Martinez-Lopez, Joaquin
AU  - Montesinos, Pau
PY  - 2022
DO  - 10.3390/cancers14235799
SN  - 2072-6694
UR  - http://hdl.handle.net/20.500.12105/16136
AB  - FLT3−ITD results in a poor prognosis in terms of overall survival (OS) and relapse-free survival (RFS) in acute myeloid leukemia (AML). However, the prognostic usefulness of the allelic ratio (AR) to select post-remission therapy remains...
LA  - eng
PB  - Multidisciplinary Digital Publishing Institute (MDPI)
KW  - FLT3-ITD mutation and ratio
KW  - real-world outcomes
KW  - ACUTE MYELOID LEUKEMIA
KW  - PROGNOSIS
KW  - OUTCOME
KW  - DEATH
KW  - RELAPSE
KW  - SURVIVAL
TI  - Impact of FLT3-ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study.
TY  - journal article
ER  -